United Therapeutics CEO Martine A. Rothblatt reports disposal of $5.08 million in common shares
UTHR•United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 common shares on October 16, 2026, and exercised options for 9,500 shares at $117.76 apiece. After the transactions, indirect holdings through trusts totaled 324,443 shares and direct holdings totaled 40,513 shares.
1. Share transactions
Martine A. Rothblatt sold 9,500 United Therapeutics common shares on October 16, 2026, and exercised stock options for 9,500 common shares at $117.76 per share. The transactions left 324,443 shares held indirectly through trusts involved in the trades and 40,513 shares held directly.
